Kimberly-Clark has a plan improve growth and earnings following its acquisition of Kenvue
Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
Source: CNBC
Original reporting
CNBC: read the full reportRelated stories
CNBC
Palantir reports booming U.S. commercial revenue growth, topping government for first time
Palantir's commercial revenue jumped 148% to $984 million, surpassing government revenue of $953 million.
CNBC
Intel foundry push faces critical test after stock's 45% plunge in October
Intel’s turnaround now hinges on proving its foundry strategy can deliver, as customers look for signs the company will add fab capacity and catch TSMC
CNBC
Trump focuses on Reflecting Pool in final public speech before midterms
Trump seemed to acknowledge that Democrats had an advantage heading into Election Day. "But we gave this a very strong shot," he said.
CNBC
Texas governor race tightens in prediction markets, but Abbott remains favored
Prediction markets still show the Republican incumbent favored to win a fourth term, but the odds have narrowed in recent weeks.
CNBC
Oracle files to sell $20 billion in new stock, bonds to finance AI buildout
Oracle filed plans on Monday to issue new shares and more debt to finance its artificial intelligence buildout.
CNBC
Lumentum CEO touts 'enormous' opportunity in massive AI connectivity deal with Marvell
The AI infrastructure deal is expected to close during the first half of 2028.